As COVID-19 continues to impact us, principle investigator meetings are off the table. Or are they? Yes, you can pull off an effective, virtual investigator meeting for your clinical trial. Here’s how to make sure you do.
Implementing clinical trial readiness enables you to confidently predict who will succeed in conducting your clinical trial – and who needs more preparation.
You’re using the clinical trial site selection checklist you’ve always used, but you’re still struggling with the same delays, site problems, and retraining you see in every trial. Why? It’s time to adjust the way you measure your sites for selection.
Read this excerpt from our eBook.
Clinical trial readiness is an essential part of keeping the many people who participate in clinical trials safe while ensuring the trial runs smoothly, remains in compliance, and stays within budget.
We join our partners in celebrating Pride Month, because LGBTQ+ rights are human rights. ArcheMedX will always stand with the LBGTQ+ community, with Black Lives Matter, and with anyone who seeks to advance true, meaningful Equality for all. Read our statement in support of Pride Month here.
Clinical trial readiness has to do with building systems within a clinical trial that better prepare all project staff for the challenges and responsibilities they will face during the trial. Readiness can relate to sites, staff, and even patients — and its impact can be monumental.
The COVID-19 pandemic has forced clinical research to make bold changes to survive. Pharma Initiatives’ Mark Shapiro joined ArcheMedX to discuss what changes are temporary – and what will be true disruption.
ArcheMedX helps life sciences and healthcare organizations to better equip, evaluate, and predict team and clinician performance
